Search Results
10
Everything
Direct-to-Consumer Genetic Testing Market Size Set to Reach $7.19 Billion by 2030, Driven by Growing Awareness and Technological Advancements | The Insight Partners
March 26, 2025 09:50 ET
|
The Insight Partners
US & Canada, March 26, 2025 (GLOBE NEWSWIRE) -- According to a comprehensive report from The Insight Partners, “Direct-To-Consumer Genetic Testing Market Size and Forecast (2025–2031), Global...
Baylor Genetics Presents New Data on Genetic and Functional Testing to Diagnose Mitochondrial Disorders at 2025 ACMG Annual Clinical Genetics Meeting
March 21, 2025 16:30 ET
|
Baylor Genetics
HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory celebrating a decade at the forefront of genetic testing, today shared research on the value of both...
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools
February 27, 2025 16:15 ET
|
Myriad Genetics, Inc.
Myriad Genetics announced a collaboration with Gabbi to provide an integrated offering for breast cancer risk assessment.
Analysis of China's Potential $16.4 Bn Genetic Testing Market, 2025-2033 - Featuring Key Players BGI, Berry Genomics Co., Daan Gene Co., WuXi NextCODE, Annoroad Gene Technology Co., and WuXi PharmaTech
February 27, 2025 06:04 ET
|
Research and Markets
Dublin, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The "China Genetic Testing Market by Test Type, Disease, Technology, Service Provider, Testing Sample 2025-2033" report has been added to ...
Myriad Genetics Announces Senior Leadership Transition
February 24, 2025 16:05 ET
|
Myriad Genetics, Inc.
Myriad Genetics announces senior leadership transition; Sam Raha as CEO and Mark S. Verratti as COO effective April 30, 2025.
Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio
February 24, 2025 08:30 ET
|
Myriad Genetics, Inc.
Myriad Genetics entered into a strategic collaboration with PATHOMIQ to exclusively license its AI technology platform for prostate cancer in the US.
Myriad Genetics Included in Forbes America’s Best Employers 2025 List
February 19, 2025 08:30 ET
|
Myriad Genetics, Inc.
Myriad Genetics has been named on the Forbes list of America’s Best Employers 2025.
Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
February 18, 2025 08:30 ET
|
Myriad Genetics, Inc.
Myriad Genetics will hold its fourth quarter and full year 2024 earnings conference call at 4:30 pm ET on Monday, Feb. 24, 2025.
Baylor Genetics Marks a Decade of Leadership in Precision Diagnostics, Empowering Patients, Healthcare Providers and Partners with Trusted Genetic Insights
February 11, 2025 10:00 ET
|
Baylor Genetics
Baylor Genetics marks its 10-year anniversary this month, a milestone that demonstrates the company's long-term commitment to precision diagnostics.
Myriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer Test
February 06, 2025 08:30 ET
|
Myriad Genetics, Inc.
Myriad Genetics and CancerCARE for Life announced an agreement designed to enhance education and access to hereditary cancer testing.